EU Health Policy Platform Calls for Proposals: 2021 Thematic Networks

European CommissionThe European Commission is inviting public health stakeholders to submit initiatives for anew cycle of Thematic Networks under the EU Health Policy Platform. The purpose of a Thematic Network is to produce a Joint Statement within a year, summarising the common position of a group of stakeholder organisations on one of the following selected public health areas:
  • Adaptation actions on climate change and health
  • Health inequalities with regard to ethnic minorities and racism
  • Improving public information on the health effects of air pollution
  • Integrative Oncology in patient-centred cancer care
  • The Pharmaceutical Strategy

The European Commission may also consider proposals from other policy areas if stakeholders from other fields of public health present sound reasons for doing so; or combinations of several policy areas mentioned above.

The Joint Statements shall advice the European Commission on its policy activities and shall encourage the stakeholder's community to join forces and carry out their own activities/initiatives in synergy with those carried out by the Commission and the Member States. For this reason, proposals addressed by Thematic Networks should be in line with the EU health policy agenda. Thematic networks are encouraged to make use of all the information made available to them to prepare Joint Statements that engage the commitment of the stakeholder community.

Joint Statements are not binding for the European Commission. They are owned by the organisation leading the Thematic Network. The work on the Joint Statements is the responsibility of the organisations involved in drafting it through the Health Policy Platform. Ideally, Joint Statements should commit the stakeholder's community to carry out work in the selected domains in synergy with the action taken by the European Commission informing about the relevant challenges, solutions and best practices.

To apply please:

  • Prepare a brief summary of your proposal (maximum 2 pages)
    • Include the scope of your future Joint Statement
    • Explain the relevance of your proposal for the selected area and the possible synergy with ongoing or planned EU actions on health in the European Union
    • State your objectives and how you will reach them
    • List your possible network and partners involved (you can include logos if you wish)
    • State the leading organisation clearly
    • Contact person and details
  • Send your proposal to the email address: This email address is being protected from spambots. You need JavaScript enabled to view it.
  • Deadline: 7 June 2021

The European Commission will evaluate the proposals received by topic and select a maximum of 6. These 6 proposals will be presented in a poll in the Agora network (the main network of the EU Health Policy Platform), where all registered users of the Platform will be allowed to vote. The poll will be open during three weeks. We encourage stakeholders to register in advance in the EU Health Policy Platform to vote for their preferred Thematic Network, as last-minute registrations cannot be guaranteed.

The 3 proposals with the most votes in the EU Health Policy Platform poll will be considered as the final proposals for the 2021 Thematic Networkscycle, and will kick-off immediately after the poll, and at the latest in early September 2021.

Most Popular Now

The Future of Medicine is Data

At the 2023 Annual J.P. Morgan Healthcare Conference, Owkin Co-founder and CEO Thomas Clozel, MD will outline how data is the future of medicine - from the development of new...

Study Surveys Landscape of Apps Built on…

A study led by Regenstrief Institute Research Scientist Titus K. Schleyer, DMD, PhD, is among the first to survey the current landscape of FHIR® apps, providing a snapshot of how...

New Computer Program 'Learns' to Identif…

Genetic mutations cause hundreds of unsolved and untreatable disorders. Among them, DNA mutations in a small percentage of cells, called mosaic mutations, are extremely difficult to detect because they exist...

Applications Open for SpinLab Accelerato…

The start-up accelerator supports entrepreneurial and innovative teams that want to grow sustainably and successfully scale their business model. With a strong hands-on mentality and a lot of passion, the...

Bayer to Accelerate Drug Discovery with …

Bayer AG and Google Cloud today announced a collaboration to drive early drug discovery that will apply Google Cloud's Tensor Processing Units (TPUs), which are custom-developed accelerators designed to run...

Allscripts Announces Corporate Name Chan…

Allscripts Healthcare Solutions, Inc. announced that, effective January 1, 2023, it has changed its name to Veradigm Inc. (NASDAQ: MDRX). Allscripts had been transitioning its solutions to the Veradigm brand...

220M€ Investment in Testing and Experime…

To make the EU the place where AI excellence thrives from the lab to the market, the European Union is setting up world-class Testing and Experimentation Facilities (TEFs) for AI. Together...

AI Tool Developed to Predict Risk of Lun…

Lung cancer is the leading cause of cancer death in the United States and around the world. Low-dose chest computed tomography (LDCT) is recommended to screen people between 50 and...

Artificial Nerve Cells - Almost Like Bio…

Researchers at Linköping University (LiU), Sweden, have created an artificial organic neuron that closely mimics the characteristics of biological nerve cells. This artificial neuron can stimulate natural nerves, making it...

Bayer Acquires Blackford Analysis Ltd. B…

Bayer announced the acquisition of the global strategic imaging AI platform and solutions provider Blackford Analysis Ltd. The acquisition is part of Bayer's strategy to drive innovation in radiology, including...

For Shared Decision-Making, Telemedicine…

Telemedicine may be just as effective as in-person visits when it comes to shared decision-making and communication for patients undergoing a first-time surgery consultation, according to a study published as...

Veradigm Announces Strategic Investment …

Veradigm Inc. (NASDAQ: MDRX), formerly Allscripts Healthcare Solutions, Inc., announced an investment in Holmusk, a global behavioral health real-world evidence and data analytics company, as part of Holmusk's $45 million...